4108 Stock Overview
Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
PhytoHealth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$15.80 |
| 52 Week High | NT$23.50 |
| 52 Week Low | NT$15.75 |
| Beta | 1.06 |
| 1 Month Change | -2.47% |
| 3 Month Change | -12.47% |
| 1 Year Change | -26.51% |
| 3 Year Change | -32.19% |
| 5 Year Change | -12.22% |
| Change since IPO | -72.76% |
Recent News & Updates
Shareholder Returns
| 4108 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -1.9% | -0.01% | -2.1% |
| 1Y | -26.5% | -2.7% | 25.6% |
Return vs Industry: 4108 underperformed the TW Pharmaceuticals industry which returned -2.7% over the past year.
Return vs Market: 4108 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 4108 volatility | |
|---|---|
| 4108 Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4108 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4108's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | I-Lin Lee | www.phytohealth.com.tw |
PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. The company operates in three segments: Pharmaceutical Drugs and Dietary Supplement, Medical Diagnostic Products, and Precision Medical Equipment. The Pharmaceutical Drugs and Dietary Supplement segment manufactures and sells Chinese medicine and new pharmaceutical products.
PhytoHealth Corporation Fundamentals Summary
| 4108 fundamental statistics | |
|---|---|
| Market cap | NT$3.14b |
| Earnings (TTM) | -NT$86.82m |
| Revenue (TTM) | NT$163.13m |
19.2x
P/S Ratio-36.1x
P/E RatioIs 4108 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4108 income statement (TTM) | |
|---|---|
| Revenue | NT$163.13m |
| Cost of Revenue | NT$98.02m |
| Gross Profit | NT$65.12m |
| Other Expenses | NT$151.93m |
| Earnings | -NT$86.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.44 |
| Gross Margin | 39.92% |
| Net Profit Margin | -53.22% |
| Debt/Equity Ratio | 0% |
How did 4108 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 12:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PhytoHealth Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiahong Liu | E.Sun Securities Investment Consulting Co. Ltd. |
| Li-chun Chang | Jih Sun Securities Investment Consulting Co., Ltd. |
| Pravin Gondhale | Virtua Research Inc. |